Reference
Ruck T, et al. Pretreatment anti-thyroid autoantibodies indicate increased risk for thyroid autoimmunity secondary to alemtuzumab: A prospective cohort study. EBioMedicine 46: 381-386, Aug 2019. Available from: URL: https://doi.org/10.1016/j.ebiom.2019.07.062 - Germany
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 1772, 21 (2019). https://doi.org/10.1007/s40278-019-68148-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-68148-z